Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma

Chihiro Miyamoto(The University of Tokyo), Masaichi‐Chang‐il Lee(Kanagawa Dental University), Shunsuke Takahashi(Kanagawa Dental University), Shigeyuki Ozawa(Kanagawa Dental University), Kouki Hidaka(Kanagawa Dental University), Satoko Wada-Takahashi(Kanagawa Dental University), Yojiro Maehata, Takeharu Ikoma(Kanagawa Dental University), Ayaka Yoshida(Kanagawa Dental University), Ryu‐Ichiro Hata(Kanagawa Dental University), Fumihiko Yoshino(Kanagawa Dental University), Eiro Kubota(Kubota (Japan)), Kazuhiko MOTOHASHI(Kanagawa Dental University)
Biomedical Research
January 1, 2014
Cited by 13


Related Papers